Orexigen Therapeutics (OREX) Holders Approval of All Proposals Include 1-for-10 Reverse Stock Split
Tweet Send to a Friend
Orexigen Therapeutics, Inc. (NASDAQ: OREX) announced stockholder approval of all proposals at its 2016 Annual Meeting held earlier today. Orexigen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
